High-on-Aspirin Platelet Reactivity Differs Between Recurrent Ischemic Stroke Associated With Extracranial and Intracranial Atherosclerosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Ischemic stroke recurs despite the use of antiplatelet agents. Various mechanisms are involved in recurrence due to intracranial atherosclerosis (ICAS) and extracranial atherosclerosis (ECAS). High-on-aspirin platelet reactivity (HAPR) may differ between recurrent stroke due to ICAS and ECAS. Methods Patients with recurrent ischemic stroke as a result of large-artery atherosclerosis despite taking aspirin were enrolled consecutively. Ischemic stroke was classified as stroke due to ICAS or ECAS according to the location of the culprit stenosis. An aspirin reaction units (ARU) value of >550 IU was defined as HAPR. HAPR and its associated factors were compared between the two groups and also considering the mechanism of stroke. Results Among the 190 patients with recurrent stroke (111 with ICAS and 79 with ECAS), 36 (18.3%) showed HAPR. The ARU value was higher in the ECAS than the ICAS group (492± 83 vs. 465±78, mean±standard deviation; p=0.028), as was the proportion of patients with HAPR (27.8% vs. 12.6%, p=0.008). Being male and having stroke due to ECAS (reference = stroke due to ICAS: odds ratio=5.760; 95% confidence interval=2.154–15.403; p<0.001) was independently associated with HAPR. The ARU value differed according to the stroke mechanism, and was highest in those with artery-to-artery embolism. Artery-to-artery embolism was independently associated with HAPR in both the ICAS and ECAS groups. Conclusions Recurrent stroke due to ECAS was more strongly associated with HAPR and insufficient antiplatelet inhibition than was that due to ICAS. Artery-to-artery embolism was associated with HAPR in recurrent ischemic stroke as a result of ICAS or ECAS.
Abstract
Background and Purpose Ischemic stroke recurs despite the use of antiplatelet agents. Various mechanisms are involved in recurrence due to intracranial atherosclerosis (ICAS) and extracranial atherosclerosis (ECAS). High-on-aspirin platelet reactivity (HAPR) may differ between recurrent stroke due to ICAS and ECAS. Methods Patients with recurrent ischemic stroke as a result of large-artery atherosclerosis despite taking aspirin were enrolled consecutively. Ischemic stroke was classified as stroke due to ICAS or ECAS according to the location of the culprit stenosis. An aspirin reaction units (ARU) value of >550 IU was defined as HAPR. HAPR and its associated factors were compared between the two groups and also considering the mechanism of stroke. Results Among the 190 patients with recurrent stroke (111 with ICAS and 79 with ECAS), 36 (18.3%) showed HAPR. The ARU value was higher in the ECAS than the ICAS group (492± 83 vs. 465±78, mean±standard deviation; p=0.028), as was the proportion of patients with HAPR (27.8% vs. 12.6%, p=0.008). Being male and having stroke due to ECAS (reference = stroke due to ICAS: odds ratio=5.760; 95% confidence interval=2.154–15.403; p<0.001) was independently associated with HAPR. The ARU value differed according to the stroke mechanism, and was highest in those with artery-to-artery embolism. Artery-to-artery embolism was independently associated with HAPR in both the ICAS and ECAS groups. Conclusions Recurrent stroke due to ECAS was more strongly associated with HAPR and insufficient antiplatelet inhibition than was that due to ICAS. Artery-to-artery embolism was associated with HAPR in recurrent ischemic stroke as a result of ICAS or ECAS.
참고문헌 (23)
- 김범준, "Ischemic Stroke Subtype Classification: An Asian Viewpoint", 대한뇌졸중영문학회지, 16(1), pp.8~17 (2014), 대한뇌졸중학회[DOI]
- Georgios Tsivgoulis, "Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke", 대한뇌졸중영문학회지, 20(2), pp.145~166 (2018), 대한뇌졸중학회
- Bornstein NM, "Failure of aspirin treatment after stroke", Stroke, 25, pp.275~277 (1994)
- Shin DH, "Mechanisms of recurrence in subtypes of ischemic stroke : a hospital-based follow-up study", Arch Neurol, 62, pp.1232~1237 (2005)
- Yi X, "Clopidogrel resistance increases rate of recurrent stroke and other vascular events in Chinese population", J Stroke Cerebrovasc Dis, 25, pp.1222~1228 (2016)
- Kim BJ, "Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography", Stroke, 43, pp.727~732 (2012)
- Kim BJ, "Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting", J Neurosurg, 121, pp.891~898 (2014)
- Kim JS, "Risk factors and stroke mechanisms in atherosclerotic stroke : intracranial compared with extracranial and anterior compared with posterior circulation disease", Stroke, 43, pp.3313~3318 (2012)
- 방오영, "Intracranial Atherosclerosis: Current Understanding and Perspectives", 대한뇌졸중영문학회지, 16(1), pp.27~35 (2014), 대한뇌졸중학회[DOI]
- Mason PJ, "Aspirin resistance and atherothrombotic disease", J Am Coll Cardiol, 46, pp.986~993 (2005)
- Shim CY, "The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation", Int J Cardiol, 134, pp.351~355 (2009)
- Groen HC, "Plaque rupture in the carotid artery is localized at the high shear stress region : a case report", Stroke, 38, pp.2379~2381 (2007)
- Wang Y, "High shear stress induces atherosclerotic vulnerable plaque formation through angiogenesis", Regen Biomater, 3, pp.257~267 (2016)
- O’Brien JR, "Shear-induced platelet aggregation", Lancet, 335, pp.711~713 (1990)
- Valerio L, "Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices", Thromb Res, 140, pp.110~117 (2016)
- Dawson J, "Microembolic signals and aspirin resistance in patients with carotid stenosis", Cardiovasc Ther, 30, pp.234~239 (2012)
- Wu F, "Hyperintense plaque on intracranial vessel wall magnetic resonance imaging as a predictor of artery-to-artery embolic infarction", Stroke, 49, pp.905~911 (2018)
- Kim JM, "Intracranial plaque enhancement from high resolution vessel wall magnetic resonance imaging predicts stroke recurrence", Int J Stroke, 11, pp.171~179 (2016)
- Young Jun Choi, "Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries", 대한뇌졸중영문학회지, 17(3), pp.238~255 (2015), 대한뇌졸중학회
- Jeon SB, "Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke", Eur Neurol, 64, pp.51~57 (2010)
- Kim JT, "Different antiplatelet strategies in patients with new ischemic stroke while taking aspirin", Stroke, 47, pp.128~134 (2016)
- Johnson GJ, "Measurement of shear-activated platelet aggregate formation in nonanticoagulated blood : utility in detection of clopidogrel-aspirin-induced platelet dysfunction", Clin Appl Thromb Hemost, 18, pp.140~149 (2012)
- Kwon SU, "Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis", Stroke, 42, pp.2883~2890 (2011)